| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/24/2012 | US8101818 Enhancement of hydroxy fatty acid accumulation in oilseed plants |
| 01/24/2012 | US8101744 Isolation and purification of nucleic acids with a solid phase |
| 01/24/2012 | US8101743 Modulation of transthyretin expression |
| 01/24/2012 | US8101742 Method and medicament for inhibiting the expression of a given gene |
| 01/24/2012 | US8101741 Modified siRNA molecules and uses thereof |
| 01/24/2012 | US8101740 Positron emission tomography probes for imaging immune activation and selected cancers |
| 01/24/2012 | US8101739 Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector |
| 01/24/2012 | US8101738 ABFB-2 gene from Penicillium funiculosum |
| 01/24/2012 | US8101737 Parallel preparation of high fidelity probes in an array format |
| 01/24/2012 | US8101736 Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same |
| 01/24/2012 | US8101735 Preparation of protective antigen |
| 01/24/2012 | US8101734 Ghrelin binding nucleic acids |
| 01/24/2012 | US8101585 Compositions and methods for the modulation of JNK proteins |
| 01/24/2012 | US8101584 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 01/24/2012 | US8101563 Proteases from gram-positive organisms |
| 01/24/2012 | US8101416 Sample suspected of containing the target polynucleotide is contacted with a polycationic multichromophore and a sensor polynucleotide complementary to the target polynucleotide; kits |
| 01/24/2012 | US8101406 Protective anti-glucan antibodies with preference for β-1,3-glucans |
| 01/24/2012 | US8101398 Modified cellulases with increased thermostability, thermophilicity, and alkalophilicity |
| 01/24/2012 | US8101395 Halohydrin dehalogenases and related polynucleotides |
| 01/24/2012 | US8101394 Recombinantly modified plasmin |
| 01/24/2012 | US8101393 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| 01/24/2012 | US8101392 Glucoamylase variants |
| 01/24/2012 | US8101390 Mutant-type acetyltransferase Mpr1 |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | US8101380 Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs |
| 01/24/2012 | US8101365 Anti-EphB4 antibodies and methods using same |
| 01/24/2012 | US8101362 Detection of Clostridium difficile |
| 01/24/2012 | US8101361 Markers for diagnosis of pulmonary inflammation and methods related thereto |
| 01/24/2012 | US8101360 IL-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same |
| 01/24/2012 | US8101359 Using CpG site methylation of breast cancer tumor antigens as evaluative tools in prognosing/diagnosing cell proliferative disorders |
| 01/24/2012 | US8101354 Method for screening for a tobiano coat color genotype |
| 01/24/2012 | US8101351 Process for typing of HCV isolates |
| 01/24/2012 | US8101350 Modulation of exportin 5 expression |
| 01/24/2012 | US8101349 For use in diagnostics and therapeutics |
| 01/24/2012 | US8101348 RNA-interference by single-stranded RNA molecules |
| 01/24/2012 | US8101346 Identifier and nucleic acid amplification method of verification using the same |
| 01/24/2012 | US8101344 freezing and thawing whole blood, then lysing leukocytes of the whole blood, and quantifying the specific mRNA in the lysate; lysate is transferred to an oligo(dT)-immobilized plate to capture the mRNA; use screening blood banks for HIV for example |
| 01/24/2012 | US8101343 protecting against parasites and predators; transgenic organisims |
| 01/24/2012 | US8101193 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 01/24/2012 | US8101177 Anti-VEGF antibodies |
| 01/24/2012 | CA2631829C New method for bisulfite treatment |
| 01/24/2012 | CA2510477C Process for the preparation of oligonucleotides |
| 01/24/2012 | CA2406168C Polyamide nucleic acid derivatives, agents and methods for producing same |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2221318C High affinity oligonucleotide ligands to growth factors |
| 01/19/2012 | WO2012008465A1 (nucleic acid)-polysaccharide complex |
| 01/19/2012 | WO2012006732A1 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction |
| 01/19/2012 | WO2011146825A3 Avian influenza h5n1 specific aptamers and their use |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011130491A3 Methods and compositions for treating hiv |
| 01/19/2012 | WO2009151503A3 Compositions and methods for the treatment of a neoplasia |
| 01/19/2012 | US20120017332 Process for the production of arachidonic acid and/or eicosapentaenoic acid |
| 01/19/2012 | US20120017329 Squash leaf curl virus (slcv) resistance in cucurbits |
| 01/19/2012 | US20120017291 Squash leaf curl virus (slcv) resistance in cucurbits |
| 01/19/2012 | US20120016110 Method of immobilizing and stretching a nucleic acid on a substrate |
| 01/19/2012 | US20120016107 Growth factor htter36 |
| 01/19/2012 | US20120016106 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8 associated disorders |
| 01/19/2012 | US20120016011 RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/19/2012 | US20120016010 RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/19/2012 | US20120016008 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) |
| 01/19/2012 | US20120016007 Small interference rna complex with increased intracellular transmission capacity |
| 01/19/2012 | US20120016005 Phagocytic cell delivery of rnai |
| 01/19/2012 | US20120016004 Compositions for inhibiting gene expression and uses thereof |
| 01/19/2012 | US20120016003 Pot1 alternative splicing variants |
| 01/19/2012 | US20120015888 T cell receptors and related materials and methods of use |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015874 Novel inhibitors of retroviral reverse transcriptace |
| 01/19/2012 | US20120015850 siRNA targeting Superoxide |
| 01/19/2012 | US20120015831 Method for delivering nucleic acid into eukaryotic genomes |
| 01/19/2012 | US20120015830 Microrna profiles for evaluating multiple sclerosis |
| 01/19/2012 | US20120015827 Method for therapy prediction in tumors having irregularities in the expression of at least one vegf ligand and/or at least one erbb-receptor |
| 01/19/2012 | US20120015810 Tubulin regulatory elements for use in plants |
| 01/19/2012 | US20120015437 Long-acting polypeptides and methods of producing same |
| 01/19/2012 | US20120015435 Pcsk9 antagonists |
| 01/19/2012 | US20120015432 Isolated bitter taste receptor polypeptides |
| 01/19/2012 | US20120015410 Pyripyropene a biosynthetic gene |
| 01/19/2012 | US20120015405 Dna polymerases with increased 3'-mismatch discrimination |
| 01/19/2012 | US20120015401 Plasmodium falciparum antigens and methods of use |
| 01/19/2012 | US20120015370 Multiplex compositions and methods for quantification of human nuclear dna and human male dna and detection of pcr inhibitors |
| 01/19/2012 | US20120015364 Method for the selection of endothelial cells death inducers via netrin-1 and its applications |
| 01/19/2012 | US20120015362 Compositions and methods for detecting cryptococcus neoformans |
| 01/19/2012 | US20120015361 Oligonucleotides For The Detection Of Aspergillus Species |
| 01/19/2012 | US20120015358 Orthogonal nucleic acid affinity pairs |
| 01/19/2012 | US20120015355 Size standards for use in nucleic acid analysis |
| 01/19/2012 | US20120015354 Nucleic acid aptamer binder specifically to bisphenol a |
| 01/19/2012 | US20120015349 Compositions for use in identification of papillomavirus |
| 01/19/2012 | US20120015346 Influenza virus detection and diagnosis |
| 01/19/2012 | US20120015345 Identification of Oligonucleotides for the Capture, Detection and Quantitation of West Nile Virus |
| 01/19/2012 | US20120015049 Microrna biomarker in cancer |
| 01/19/2012 | US20120015042 Rna sequence-specific mediators of rna interference |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014996 Method of diagnosing bladder cancer |
| 01/19/2012 | US20120014988 Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements |
| 01/19/2012 | US20120014982 Methods and Compositions for Immunizing Against Chlamydia Infection |
| 01/19/2012 | US20120014977 NOVEL ALTERNATIVE SPLICING VARIANT OF OATP1B3 mRNA |
| 01/19/2012 | US20120014964 Alpha synuclein toxicity |
| 01/19/2012 | US20120014941 Anti-bv8 antibodies and uses thereof |
| 01/19/2012 | US20120014920 Annexin and its use to treat inflammatory disorders |
| 01/19/2012 | US20120014877 COMPOSITIONS AND METHODS TO TREAT CANCER WITH CpG RICH DNA AND CUPREDOXINS |
| 01/19/2012 | US20120014875 Nucleic acid aptamers |